BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Manzoor S, Saalim M, Imran M, Resham S, Ashraf J. Hepatitis B virus therapy: What’s the future holding for us? World J Gastroenterol 2015; 21(44): 12558-12575 [PMID: 26640332 DOI: 10.3748/wjg.v21.i44.12558]
URL: https://www.wjgnet.com/1007-9327/full/v21/i44/12558.htm
Number Citing Articles
1
Aina-Cathrine Øvergård, Lars Are Hamre, Heidi Kongshaug, Frank Nilsen. RNAi-mediated treatment of two vertically transmitted rhabdovirus infecting the salmon louse (Lepeophtheirus salmonis)Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14282-3
2
James Fung, Ching-Lung Lai, Wai-Kay Seto, Man-Fung Yuen. Emerging drugs for the treatment of hepatitis BExpert Opinion on Emerging Drugs 2016; 21(2): 183 doi: 10.1517/14728214.2016.1162155
3
Jung-Ah Kang, Songwon Kim, Minji Park, Hyun-Jin Park, Jeong-Hyun Kim, Sanghyeok Park, Jeong-Ryul Hwang, Yong-Chul Kim, Yoon Jun Kim, Yuri Cho, Mi Sun Jin, Sung-Gyoo Park. Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assemblyNature Communications 2019; 10(1) doi: 10.1038/s41467-019-10200-5
4
Sebastien Boucle, Leda Bassit, Maryam Ehteshami, Raymond F. Schinazi. Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined ModalitiesClinics in Liver Disease 2016; 20(4): 737 doi: 10.1016/j.cld.2016.07.001
5
Xiaojun Sun, Chengwei Wang, Bian Wang, Xiuzhen Yang, Hongtao Xu, Meilong Shen, Kuichun Zhu, Susan Cu-Uvin. Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese GroupInfectious Diseases in Obstetrics and Gynecology 2020; 2020: 1 doi: 10.1155/2020/4305950
6
Yin Zhang, Yanming Xie, Yiying Zhang, Yan Liu, Yan Zhuang. Hepatitis B patients exhibiting mild alanine aminotransferase elevation: A comparative analysis of treatment with and without Bicyclol tabletsBiomedical Reports 2016; 5(5): 595 doi: 10.3892/br.2016.765
7
Young Li, Yang Wu, Xiaohu Zheng, Jingjing Cong, Yanyan Liu, Jiabin Li, Rui Sun, Zhigang G. Tian, Haiming M. Wei. Cytoplasm-Translocated Ku70/80 Complex Sensing of HBV DNA Induces Hepatitis-Associated Chemokine SecretionFrontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00569
8
Haiyong Jia, Yang Song, Ji Yu, Peng Zhan, Diwakar Rai, Xiaohong Liang, Chunhong Ma, Xinyong Liu. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitorsEuropean Journal of Medicinal Chemistry 2017; 136: 144 doi: 10.1016/j.ejmech.2017.04.048
9
Jing Tu, Jiao Jiao Li, Zhi Jie Shan, Hong Lin Zhai. Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D-QSAR and molecular dynamicsAntiviral Research 2017; 137: 151 doi: 10.1016/j.antiviral.2016.11.026
10
Sei Yonezawa, Hiroyuki Koide, Tomohiro Asai. Recent advances in siRNA delivery mediated by lipid-based nanoparticlesAdvanced Drug Delivery Reviews 2020; : 64 doi: 10.1016/j.addr.2020.07.022
11
Jingying Qiu, Qineng Gong, Jian Gao, Wang Chen, Yinpeng Zhang, Xiaoke Gu, Daoquan Tang. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitorsEuropean Journal of Medicinal Chemistry 2018; 144: 424 doi: 10.1016/j.ejmech.2017.12.042
12
Soo-Hyun Park, Kyung-Seok Park, Nam-Hee Kim, Joong-Yang Cho, Moon Soo Koh, Jin Ho Lee. Clevudine Induced Mitochondrial MyopathyJournal of Korean Medical Science 2017; 32(11): 1857 doi: 10.3346/jkms.2017.32.11.1857
13
Dongki Yang. Application of Nanotechnology in the COVID-19 PandemicInternational Journal of Nanomedicine 2021; : 623 doi: 10.2147/IJN.S296383
14
Lavanya Singh, Hendrik G. Kruger, Glenn E.M. Maguire, Thavendran Govender, Raveen Parboosing. The role of nanotechnology in the treatment of viral infectionsTherapeutic Advances in Infectious Disease 2017; 4(4): 105 doi: 10.1177/2049936117713593
15
Jonathan Forde, Stanca Ciupe, Ariel Cintron-Arias, Suzanne Lenhart. Optimal Control of Drug Therapy in a Hepatitis B ModelApplied Sciences 2016; 6(8): 219 doi: 10.3390/app6080219
16
Wu Guicheng, An Xuan, Xiang Yi, Wei Fang, Xia Lina, Zhong Qing, Du Biao, Liu Yong. Effect of Cytotoxic T Lymphocytes Induced by Recombinant Adeno-Associated Virus on Different Hepatitis B Virus GenesHepatitis Monthly 2016; 17(5) doi: 10.5812/hepatmon.42685
17
Uma S. Singh, Varughese A. Mulamoottil, Chung K. Chu. 2′-Fluoro-6′-methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti-HBV agent, active against drug-resistant HBV mutantsMedicinal Research Reviews 2018; 38(3): 977 doi: 10.1002/med.21490
18
Yongning Xin, Wei Li, Linlin Lu, Li Zhou, David W. Victor, Shiying Xuan. Antiviral effects of Stichopus japonicus acid mucopolysaccharide on hepatitis B virus transgenic miceJournal of Ocean University of China 2016; 15(4): 719 doi: 10.1007/s11802-016-3124-4
19
Hyun Jung Jo, Gyu Nam Park, Hye Ran Kim, Min Ju Kim, Kyung A Shin, Seung Bok Hong, Kyung Soo Chang. Differences in Hematological Characteristics, Including Cholesterol and Apolipoprotein B and E, between Hepatitis B Virus and Hepatitis C Virus Patients in KoreaJournal of Bacteriology and Virology 2016; 46(3): 152 doi: 10.4167/jbv.2016.46.3.152
20
Sana Mansha, Muhammad Imran, Amir Miraj Ul Hussain Shah, Muhsin Jamal, Fayyaz Ahmed, Muhammad Atif, Muhammmad Saleem, Sher Zaman Safi, Zareen Fatima, Ahmed Bilal Waqar. Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, PakistanViral Immunology 2017; 30(5): 366 doi: 10.1089/vim.2016.0144
21
Ting Yuan, Yongfang Jiang, Mei Li, Wei Li. Chronic hepatitis B surface antigen seroclearance-related immune factorsHepatology Research 2017; 47(1): 49 doi: 10.1111/hepr.12726
22
Shrihari A. Anikhindi, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora. Ideal Cure for Hepatitis B Infection: The Target is in SightJournal of Clinical and Experimental Hepatology 2018; 8(2): 188 doi: 10.1016/j.jceh.2017.10.002
23
涛 巫. Immunotherapy for Chronic Hepatitis B Virus InfectionPharmacy Information 2019; 8(03): 105 doi: 10.12677/PI.2019.83013
24
Naoki Takizawa, Manabu Yamasaki. Current landscape and future prospects of antiviral drugs derived from microbial productsThe Journal of Antibiotics 2018; 71(1): 45 doi: 10.1038/ja.2017.115
25
Claire Pierra Rouviere, Cyril B. Dousson, John E. Tavis. HBV replication inhibitorsAntiviral Research 2020; 179: 104815 doi: 10.1016/j.antiviral.2020.104815
26
Matthias Chung, Stanca Ciupe. Understanding the Complex Patterns Observed during Hepatitis B Virus TherapyViruses 2017; 9(5): 117 doi: 10.3390/v9050117